Evidence map›Paper›PMID 33411810›Full record

Observational studyPloS one2021

Variation in hospital admission in febrile children evaluated at the Emergency Department (ED) in Europe: PERFORM, a multicentre prospective observational study.

Dorine M Borensztajn, Nienke N Hagedoorn, Irene Rivero Calle, Ian K Maconochie, Ulrich von Both, Enitan D Carrol, Juan Emmanuel Dewez, Marieke Emonts, Michiel van der Flier, Ronald de Groot and 16 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Observational
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 7 countries.

Dorine M BorensztajnDepartment of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0002-2437-0757
Nienke N HagedoornDepartment of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0001-9237-4904
Irene Rivero CalleGenetics, Vaccines, Infections and Pediatrics Research Group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.ORCID 0000-0002-3678-9264
Ian K MaconochieSection of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, United Kingdom.ORCID 0000-0001-6319-8550
Ulrich von BothDivision of Paediatric Infectious Diseases, Dr. von Hauner Children's Hospital, University Hospital, Ludwig, Ludwig-Maximilians-Universität (LMU), München, Germany.ORCID 0000-0001-8411-1071
Enitan D CarrolInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Juan Emmanuel DewezFaculty of Tropical and Infectious Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Marieke EmontsGreat North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.ORCID 0000-0002-2822-3527
Michiel van der FlierPediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Ronald de GrootStichting Katholieke Universiteit, Radboudumc Nijmegen, Nijmegen, The Netherlands.
Jethro HerbergSection of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, United Kingdom.
Benno KohlmaierDepartment of General Paediatrics, Medical University of Graz, Graz, Austria.
Emma LimGreat North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Federico Martinon-TorresGenetics, Vaccines, Infections and Pediatrics Research Group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.ORCID 0000-0002-9023-581X
Daan NieboerDepartment of Public Health, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Ruud G NijmanSection of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, United Kingdom.ORCID 0000-0001-9671-8161
Marko PokornDepartment of Infectious Diseases, University Medical Centre Ljubljana, Univerzitetni Klinični Center, Ljubljana, Slovenia.
Franc StrleDepartment of Infectious Diseases, University Medical Centre Ljubljana, Univerzitetni Klinični Center, Ljubljana, Slovenia.
Maria TsoliaSecond Department of Paediatrics, National and Kapodistrian University of Athens, P. and A. Kyriakou Children's Hospital, Athens, Greece.
Clementien VermontDepartment Pediatric Infectious Diseases & Immunology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Shunmay YeungFaculty of Tropical and Infectious Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Dace ZavadskaDepartment of Pediatrics, Rīgas Stradiņa Universitāte, Children Clinical University Hospital, Riga, Latvia.
Werner ZenzDepartment of General Paediatrics, Medical University of Graz, Graz, Austria.
Michael LevinSection of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, United Kingdom.
Henriette A MollDepartment of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
PERFORM consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union
Erasmus MC - Sophia Children’s Hospital · NLImperial College London · GBLjubljana University Medical Centre · SILondon School of Hygiene & Tropical Medicine · GBMedical University of Graz · ATNewcastle upon Tyne Hospitals NHS Foundation Trust · GBRadboud University Nijmegen · NLChildren's Clinical University Hospital · LVErasmus MC · NLLudwig-Maximilians-Universität München · DENational and Kapodistrian University of Athens · GRUniversity of Liverpool · GB

Funding

Department of Health CL-2018-21-007
6 · The paper itself

Abstract

objectivesHospitalisation is frequently used as a marker of disease severity in observational Emergency Department (ED) studies. The comparison of ED admission rates is complex in potentially being influenced by the characteristics of the region, ED, physician and patient. We aimed to study variation in ED admission rates of febrile children, to assess whether variation could be explained by disease severity and to identify patient groups with large variation, in order to use this to reduce unnecessary health care utilization that is often due to practice variation.

designMOFICHE (Management and Outcome of Fever in children in Europe, part of the PERFORM study, www.perform2020.org), is a prospective cohort study using routinely collected data on febrile children regarding patient characteristics (age, referral, vital signs and clinical alarming signs), diagnostic tests, therapy, diagnosis and hospital admission. SETTING AND

participantsData were collected on febrile children aged 0-18 years presenting to 12 European EDs (2017-2018).

main outcome measuresWe compared admission rates between EDs by using standardised admission rates after adjusting for patient characteristics and initiated tests at the ED, where standardised rates >1 demonstrate higher admission rates than expected and rates <1 indicate lower rates than expected based on the ED patient population.

resultsWe included 38,120 children. Of those, 9.695 (25.4%) were admitted to a general ward (range EDs 5.1-54.5%). Adjusted standardised admission rates ranged between 0.6 and 1.5. The largest variation was seen in short admission rates (0.1-5.0), PICU admission rates (0.2-2.2), upper respiratory tract infections (0.4-1.7) and fever without focus (0.5-2.7). Variation was small in sepsis/meningitis (0.9-1.1).

conclusionsLarge variation exists in admission rates of febrile children evaluated at European EDs, however, this variation is largely reduced after correcting for patient characteristics and therefore overall admission rates seem to adequately reflect disease severity or a potential for a severe disease course. However, for certain patient groups variation remains high even after adjusting for patient characteristics.

Indexed as

AdolescentChildChild, PreschoolDisease ProgressionEmergency Service, HospitalEuropeFemaleFeverHospitalizationHospitalsHumansInfantInfant, NewbornMaleProspective StudiesSeverity of Illness Index

Identifiers

PMID33411810
PMCPMC7790386
OpenAlexW3119815591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.